About Cognoa

OUR MISSION

Cognoa is a pediatric behavioral health company developing digital diagnostic and therapeutic products with the goals of enabling earlier and more equitable access to care and improving the lives and outcomes of children and families living with behavioral health conditions, starting with autism.

As many as 1 in 10 children have a mental, behavioral, or learning problem that interferes with their ability to function effectively in school or the community.¹

 1. Kutash K, et al. Beyond Behavior. 2015;24(2): 4-13.

Cognoa imagines a future where:

early access icon

Early Diagnosis

More children have access to early diagnosis and interventions within a critical, early neurodevelopmental window.

emergency kit icon

Streamlined Pathway to Care

Providers are equipped to act on early caregiver concerns, reliably identify behavioral conditions, expedite a diagnosis, and direct appropriate next steps in care.

family icon

Supported Parents

Caregivers are themselves supported and better equipped to positively impact the unique developmental progress of their children.

Early Diagnosis


More children have access to early diagnosis and interventions within a critical, early neurodevelopmental window.

Streamlined Pathway to Care

Providers are equipped to act on early caregiver concerns, reliably identify behavioral conditions, expedite a diagnosis, and direct appropriate next steps in care.

Supported Parents


Caregivers are themselves supported and better equipped to positively impact the unique developmental progress of their children.

young child playing with toy in pediatrician's office

We seek to improve the ASD diagnosis and treatment pathway for children, caregivers, and the healthcare community.

Early initiation of evidence-based ASD interventions during a key window of neurodevelopment leads to substantially improved long-term outcomes1. However, years can pass from the time parents first express a concern and when their child receives a diagnosis2.
  1. Estes A, et al. J Am Acad Child Adolesc Psychiatry. 2015;54(7):580-587. Strain PS, Bovey EH. Topics in Early Childhood Special Education. 2011;31(3):133-154. Peters-Sheffer N, et al. Res Autism Spectr Disord.2011;5(1):60-69.

  2. Maenner MJ, et al. MMWR Surveill Summ. 2020;69(No. SS-4):1-12. Hyman SL, et al. Pediatrics. 2020;145(1):e20193447. Baio J, et al. MMWR Surveill Summ. 2018;67(6):1-23. Zuckerman KE, et al. J Pediatr. 2015;166(6):143-149.

Cognoa is committed to:

magnifying glass icon

Efficacy

Appropriately demonstrating efficacy of our technologies with clinical data.

regulatory icon

Continuous Learning & Innovation

Understanding unmet behavioral health needs of children and families and developing tech-based approaches to help meet them.

efficient icon

Finding Efficiencies

Partnering with the payor and healthcare communities to increase efficiencies and cost-effectiveness.

Efficacy


Appropriately demonstrating efficacy of our technologies with clinical data.

Continuous Learning & Innovation

Understanding unmet behavioral health needs of children and families and developing tech-based approaches to help meet them.

Finding Efficiencies


Partnering with the payor and healthcare communities to increase efficiencies and cost-effectiveness.

Learn about our efforts to advance pediatric behavioral healthcare.

Copyright © 2022 Cognoa, Inc. All rights reserved.